Amalgamated Bank’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-300
| Closed | -$3K | – | 3084 |
|
|
2025
Q1 | $3K | Hold |
300
| – | – | ﹤0.01% | 2790 |
|
|
2024
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 2793 |
|
|
2024
Q3 | $8K | Hold |
300
| – | – | ﹤0.01% | 2558 |
|
|
2024
Q2 | $9K | Hold |
300
| – | – | ﹤0.01% | 2515 |
|
|
2024
Q1 | $13K | Sell |
300
-465
| -61% | -$20.2K | ﹤0.01% | 2325 |
|
|
2023
Q4 | $30K | Sell |
765
-89
| -10% | -$3.49K | ﹤0.01% | 2463 |
|
|
2023
Q3 | $25K | Hold |
854
| – | – | ﹤0.01% | 2547 |
|
|
2023
Q2 | $54K | Sell |
854
-41
| -5% | -$2.59K | ﹤0.01% | 2288 |
|
|
2023
Q1 | $42K | Sell |
895
-211
| -19% | -$9.9K | ﹤0.01% | 2369 |
|
|
2022
Q4 | $77K | Hold |
1,106
| – | – | ﹤0.01% | 2245 |
|
|
2022
Q3 | $162K | Buy |
1,106
+10
| +0.9% | +$1.47K | ﹤0.01% | 1931 |
|
|
2022
Q2 | $143K | Sell |
1,096
-2
| -0.2% | -$261 | ﹤0.01% | 2024 |
|
|
2022
Q1 | $111K | Buy |
+1,098
| New | +$111K | ﹤0.01% | 2156 |
|